Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Berkowitz

Showing results (491-500 of 557) with videos related to

Pageof 56
Sort By:
Cancer Genetics and Cytogenetics|December 2, 2004
Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platformHiroshi Tsuda, Michael J Birrer, Yoichi M Ito, et al.
International Journal of Cancer|December 29, 2005
Selenium binding protein 1 in ovarian cancerKuan-Chun Huang, Dong Choon Park, Shu-Kay Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancerMichael J Callahan, Zoltan Nagymanyoki, Tomas Bonome, et al.
Gynecologic Oncology|September 19, 2003
Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumorsSusanna M Campos, Ursula A Matulonis, Richard T Penson, et al.
American Journal of Obstetrics and Gynecology|April 8, 2014
What is the optimal treatment for obese patients with advanced ovarian carcinoma?Michael J Worley, Stephanie H Guseh, J Alejandro Rauh-Hain, et al.
Gynecologic Oncology|June 24, 2018
Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?Beryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, et al.
The New England Journal of Medicine|October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancerR C Bast, T L Klug, E St John, et al.
BMC Cancer|August 3, 2012
Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere culturesYu-Ting Saw, Junzheng Yang, Shu-Kay Ng, et al.
Annals of Surgical Oncology|March 8, 2021
Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian CancerBeryl L Manning-Geist, Mackenzie W Sullivan, Vishnudas Sarda, et al.
Clinics (Sao Paulo, Brazil)|July 31, 2023
Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian casesAntonio Braga, Elaine Balthar, Laís Cristhine Santos Souza, et al.
Pageof 56

Showing results (491-500 of 557) with videos related to

Sort By:
Pageof 56
Cancer Genetics and Cytogenetics|December 2, 2004
Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platformHiroshi Tsuda, Michael J Birrer, Yoichi M Ito, et al.
International Journal of Cancer|December 29, 2005
Selenium binding protein 1 in ovarian cancerKuan-Chun Huang, Dong Choon Park, Shu-Kay Ng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancerMichael J Callahan, Zoltan Nagymanyoki, Tomas Bonome, et al.
Gynecologic Oncology|September 19, 2003
Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumorsSusanna M Campos, Ursula A Matulonis, Richard T Penson, et al.
American Journal of Obstetrics and Gynecology|April 8, 2014
What is the optimal treatment for obese patients with advanced ovarian carcinoma?Michael J Worley, Stephanie H Guseh, J Alejandro Rauh-Hain, et al.
Gynecologic Oncology|June 24, 2018
Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery?Beryl L Manning-Geist, Katherine Hicks-Courant, Allison A Gockley, et al.
The New England Journal of Medicine|October 13, 1983
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancerR C Bast, T L Klug, E St John, et al.
BMC Cancer|August 3, 2012
Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere culturesYu-Ting Saw, Junzheng Yang, Shu-Kay Ng, et al.
Annals of Surgical Oncology|March 8, 2021
Disease Distribution at Presentation Impacts Benefit of IP Chemotherapy Among Patients with Advanced-Stage Ovarian CancerBeryl L Manning-Geist, Mackenzie W Sullivan, Vishnudas Sarda, et al.
Clinics (Sao Paulo, Brazil)|July 31, 2023
Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian casesAntonio Braga, Elaine Balthar, Laís Cristhine Santos Souza, et al.
Pageof 56